Use of GM-CSF to promote accelerated wound healing
US6689351B1 · kind B1 · utility
8Cited by
3References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 13, 1994 |
| Grant date | Feb 10, 2004 |
| Priority date | — |
| Expiry date | Sep 13, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method utilizing GM-CSF to promote accelerated wound healing in mammals is described. This method comprises administering topically to the mammal a therapeutically effective amount of this polypeptide. In addition, such methods comprising admixtures containing GM-CSF and at least one other protein are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.